Exodus Point Capital Management, LP Olema Pharmaceuticals, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 69,841 shares of OLMA stock, worth $439,998. This represents 0.01% of its overall portfolio holdings.
Number of Shares
69,841Holding current value
$439,998% of portfolio
0.01%Shares
5 transactions
Others Institutions Holding OLMA
# of Institutions
136Shares Held
58.7MCall Options Held
141KPut Options Held
23.1K-
Bvf Inc San Francisco, CA9.14MShares$57.6 Million3.47% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.5MShares$34.7 Million2.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$25.2 Million1.76% of portfolio
-
Black Rock Inc. New York, NY4MShares$25.2 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.69MShares$23.2 Million0.12% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $255M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...